Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 38 (5), 795-802
- https://doi.org/10.1038/ki.1990.273
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.The Journal of Experimental Medicine, 1989
- Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.The Journal of Experimental Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Cell culture approaches to the analysis of glomerular inflammationKidney International, 1986
- Enhancement of glomerular immune complex deposition by a circulating polycation.The Journal of Experimental Medicine, 1984
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- CONTRACTILE PROTEINS IN ENDOTHELIAL CELLS*Annals of the New York Academy of Sciences, 1982
- Evidence for mesangial glomerular receptors for angiotensin II linked to mesangial cell contractilityFEBS Letters, 1980
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959